These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
719 related articles for article (PubMed ID: 25766320)
21. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway. Yoo YA; Kang MH; Kim JS; Oh SC Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246 [TBL] [Abstract][Full Text] [Related]
22. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247 [TBL] [Abstract][Full Text] [Related]
23. Krüppel-like factor 17, a novel tumor suppressor: its low expression is involved in cancer metastasis. Zhou S; Tang X; Tang F Tumour Biol; 2016 Feb; 37(2):1505-13. PubMed ID: 26662959 [TBL] [Abstract][Full Text] [Related]
24. Interactions between β-catenin and transforming growth factor-β signaling pathways mediate epithelial-mesenchymal transition and are dependent on the transcriptional co-activator cAMP-response element-binding protein (CREB)-binding protein (CBP). Zhou B; Liu Y; Kahn M; Ann DK; Han A; Wang H; Nguyen C; Flodby P; Zhong Q; Krishnaveni MS; Liebler JM; Minoo P; Crandall ED; Borok Z J Biol Chem; 2012 Mar; 287(10):7026-38. PubMed ID: 22241478 [TBL] [Abstract][Full Text] [Related]
25. Gain-of-function of mutant p53: mutant p53 enhances cancer progression by inhibiting KLF17 expression in invasive breast carcinoma cells. Ali A; Shah AS; Ahmad A Cancer Lett; 2014 Nov; 354(1):87-96. PubMed ID: 25111898 [TBL] [Abstract][Full Text] [Related]
26. Disruption of the transforming growth factor-β pathway by tolfenamic acid via the ERK MAP kinase pathway. Zhang X; Min KW; Liggett J; Baek SJ Carcinogenesis; 2013 Dec; 34(12):2900-7. PubMed ID: 23864386 [TBL] [Abstract][Full Text] [Related]
27. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis. Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987 [TBL] [Abstract][Full Text] [Related]
28. Epigenetic regulation of Smad2 and Smad3 by profilin-2 promotes lung cancer growth and metastasis. Tang YN; Ding WQ; Guo XJ; Yuan XW; Wang DM; Song JG Nat Commun; 2015 Sep; 6():8230. PubMed ID: 26354229 [TBL] [Abstract][Full Text] [Related]
29. Poly(ADP-ribose) polymerase 1 is indispensable for transforming growth factor-β Induced Smad3 activation in vascular smooth muscle cell. Huang D; Wang Y; Wang L; Zhang F; Deng S; Wang R; Zhang Y; Huang K PLoS One; 2011; 6(10):e27123. PubMed ID: 22073128 [TBL] [Abstract][Full Text] [Related]
30. TGF-β1 mediates epithelial to mesenchymal transition via the TGF-β/Smad pathway in squamous cell carcinoma of the head and neck. Yu C; Liu Y; Huang D; Dai Y; Cai G; Sun J; Xu T; Tian Y; Zhang X Oncol Rep; 2011 Jun; 25(6):1581-7. PubMed ID: 21479366 [TBL] [Abstract][Full Text] [Related]
31. Retinoic acid remodels extracellular matrix (ECM) of cultured human fetal palate mesenchymal cells (hFPMCs) through down-regulation of TGF-β/Smad signaling. Li X; Zhang L; Yin X; Gao Z; Zhang H; Liu X; Pan X; Li N; Yu Z Toxicol Lett; 2014 Mar; 225(2):208-15. PubMed ID: 24374174 [TBL] [Abstract][Full Text] [Related]
32. Calreticulin regulates TGF-β1-induced epithelial mesenchymal transition through modulating Smad signaling and calcium signaling. Wu Y; Xu X; Ma L; Yi Q; Sun W; Tang L Int J Biochem Cell Biol; 2017 Sep; 90():103-113. PubMed ID: 28778674 [TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor β1 promotes invasion of human JEG-3 trophoblast cells via TGF-β/Smad3 signaling pathway. Huang Z; Li S; Fan W; Ma Q Oncotarget; 2017 May; 8(20):33560-33570. PubMed ID: 28432277 [TBL] [Abstract][Full Text] [Related]
34. The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region. Jeon WK; Choi J; Park SJ; Jo EJ; Lee YK; Lim S; Kim JH; Letterio JJ; Liu F; Kim SJ; Kim BC Oncotarget; 2015 Dec; 6(39):41650-66. PubMed ID: 26497676 [TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-β1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice. Zhang Y; Meng XM; Huang XR; Wang XJ; Yang L; Lan HY Clin Exp Pharmacol Physiol; 2014 Nov; 41(11):921-32. PubMed ID: 25132073 [TBL] [Abstract][Full Text] [Related]
36. Effect of Li S; Li Y; Tan B; An Z J Int Med Res; 2021 Nov; 49(11):3000605211051581. PubMed ID: 34738482 [TBL] [Abstract][Full Text] [Related]
37. [Effect of bone morphogenetic protein-7 on monocyte chemoattractant protein-1 induced epithelial-myofibroblast transition and TGF-beta1-Smad 3 signaling pathway of HKC cells]. Tan XY; Zheng FL; Zhou QG; Duan L; Li Y Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(37):2607-12. PubMed ID: 16321320 [TBL] [Abstract][Full Text] [Related]
38. Smad3 linker phosphorylation attenuates Smad3 transcriptional activity and TGF-β1/Smad3-induced epithelial-mesenchymal transition in renal epithelial cells. Bae E; Kim SJ; Hong S; Liu F; Ooshima A Biochem Biophys Res Commun; 2012 Oct; 427(3):593-9. PubMed ID: 23022526 [TBL] [Abstract][Full Text] [Related]
39. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis. Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047 [No Abstract] [Full Text] [Related]